Analysis
30-31 OPERATIONS - Short-changed
30 April 2026Analysis
26-27 SAFETY - SUSAR coated
30 April 2026Analysis
22-23 AI - The engagement paradox
30 April 2026Analysis
14 COLUMBUS: Pharma chameleon
30 April 2026Analysis
15-17 GLP-1S - Risky business
30 April 2026Analysis
30-31 CONDITIONS - Wake-up call
31 March 2026Analysis
22-23 PHARMA - Fast and the curious
31 March 2026Analysis
16-17 GLP-1 - Big appetite
31 March 2026Analysis
14-15 GLP-1 - Health space odyssey
31 March 2026Analysis
32-34 CANCER - New wave
31 March 2026Analysis
38 METHODS - Bay-watch
1 March 2026Analysis
26-27 CANCER - Solve and evolve
1 March 2026Analysis
PharmaTimes
PharmaTimes is the UK’s leading pharmaceutical magazine, tracking the trends and issues that affect the industry here in the UK, in Europe and across the world. We deliver independent, authoritative and trustworthy content through impartial, balanced and informed opinion and analysis.